Primary Site >> Liver Cancer

Gene >> CD33

Journal: J Nucl Med. 1993 Mar;34(3):422-30.
Title: Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemia.
Author: Sgouros, G|Graham, M C|Divgi, C R|Larson, S M|Scheinberg, D A
PMID: 8441034
Journal: Hepatology. 2000 Jun;31(6):1251-6.
Title: Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver.
Author: Golden-Mason, L|Curry, M P|Nolan, N|Traynor, O|McEntee, G|Kelly, J|Hegarty, J E|O'Farrelly, C
PMID: 10827150
Journal: Hepatol Res. 2014 Jun;44(6):639-50.
Title: Increased circulating Lin(-/low) CD33(+) HLA-DR(-) myeloid-derived suppressor cells in hepatocellular carcinoma patients.
Author: Shen, Peng|Wang, Aijuan|He, Mengye|Wang, Qingqing|Zheng, Shusen
PMID: 23701406
Journal: World J Gastrointest Pathophysiol. 2015 Aug 15;6(3):43-50.
Title: Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis.
Author: Hammerich, Linda|Tacke, Frank
PMID: 26301117
Journal: J Immunol. 2016 Mar 1;196(5):2283-92.
Title: Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-gamma Production by Altering Cellular Metabolism via Arginase-1.
Author: Goh, Celeste C|Roggerson, Krystal M|Lee, Hai-Chon|Golden-Mason, Lucy|Rosen, Hugo R|Hahn, Young S
PMID: 26826241
Journal: Gut. 2018 May;67(5):931-944.
Title: Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.
Author: Zhou, Jingying|Liu, Man|Sun, Hanyong|Feng, Yu|Xu, Liangliang|Chan, Anthony W H|Tong, Joanna H|Wong, John|Chong, Charing Ching Ning|Lai, Paul B S|Wang, Hector Kwong-Sang|Tsang, Shun-Wa|Goodwin, Tyler|Liu, Rihe|Huang, Leaf|Chen, Zhiwei|Sung, Joseph Jy|Chow,
PMID: 28939663